The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression

Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials

(2015) M. K. Neijenhuis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver Involvement in Early Autosomal-Dominant Polycystic Kidney Disease

(2015) Marie C. Hogan et al.   Clinical Gastroenterology and Hepatology

Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease

(2015) Roslyn J. Simms et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A painful inheritance—patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research

(2015) Allison Tong et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Development and validation of a polycystic liver disease complaint-specific assessment (POLCA)

(2014) Frederik Temmerman et al.   JOURNAL OF HEPATOLOGY

Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial

(2014) Tom J.G. Gevers et al.   LIVER INTERNATIONAL

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry

(2014) E. M. Spithoven et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Patient-Reported Outcomes in Clinical Trials of CKD-Related Therapies: Report of a Symposium Sponsored by the National Kidney Foundation and the US Food and Drug Administration

(2013) Ronald D. Perrone et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Health-Related Quality of Life in Patients With Autosomal Dominant Polycystic Kidney Disease and CKD Stages 1-4: A Cross-sectional Study

(2013) Dana C. Miskulin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial

(2013) Melissa Chrispijn et al.   JOURNAL OF HEPATOLOGY

Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume

(2013) Titus F. M. Wijnands et al.   LIVER INTERNATIONAL

Quality of life of patients with ADPKD—Toranomon PKD QOL study: cross-sectional study

(2013) Tatsuya Suwabe et al.   BMC Nephrology

GRADE guidelines: 7. Rating the quality of evidence—inconsistency

(2011) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

(2010) M. C. Hogan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

(2010) Andrew S. Levey et al.   KIDNEY INTERNATIONAL

Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients not yet on Dialysis

(2009) D. Rizk et al.   Clinical Journal of the American Society of Nephrology

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

(2009) Loes van Keimpema et al.   GASTROENTEROLOGY

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Unified Criteria for Ultrasonographic Diagnosis of ADPKD

(2008) Y. Pei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Autosomal Dominant Polycystic Kidney Disease

(2008) Jared J. Grantham   NEW ENGLAND JOURNAL OF MEDICINE

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY